These mutations, together with their variable expression of pan‐B‐cell (CD20) and mature B‐cell (BCL6, MUM1) markers, may argue for the existence of grey zone cases between B‐ALL/LBL and HGBCL‐NOS. Here, BCL6 is linked to acute lymphoblastic leukemia.